Instructions
This self-assessment study guide has 2 questions, each written using learning objectives from your Menstruation Disorders lecture. Not all learning objectives are covered. Participation/scores are not monitored. FYI this program makes noise sometimes.
Symbols
A clipboard will bring up relevant patient information.
A lightbulb in the top right corner of a page indicates that the page contains answers or explanations.
Question 1
The next two pages narrate a patient being diagnosed with a menstrual disorder and choosing treatment. Fill in each blank space with a term from the word bank. Type the correct answer into the corresponding box. Capatilization shouldn't matter. Press "send" after you enter your answer to recieve feedback. Alternatively, you may wait until you type all of the answers for each page before pressing the send buttons.
Question 1
A 35-year-old patient presents with abdominal pain that lasts around 2.5 weeks every month and persists through the end of her period. Based on those symptoms, it is determined that she has 1 dysmenorrhea. She is ultimately diagnosed with 2 , a disorder defined by growth of endometrial tissue outside of the uterus. She fails all first-line treatments, which include 3 , combined hormonal, and progestin-only contraceptives. This leaves her with alternative options.
- Menorrhagia
- NSAIDs
- PMDD
- Primary
- Secondary
- Dopamine agonists
- Elagolix
- Endometriosis
- Goserelin
- Letrozole
- Acetaminophen
- Agonists
- Antagonists
- Aromatase inhibitors
- Danazol
Question 1
The patient learns more about the side effect profiles of the remaining options. GnRH 4 are associated with a painful gonadotropic flare at the beginning of therapy. Classes of medications that can cause decreased BMD include GnRH agonists, GnRH antagonists, and 5 . The patient ends up being prescribed 6 , as she is okay with its potential adverse effects which include hirsutism, weight gain, and deepening of voice.
- Menorrhagia
- NSAIDs
- PMDD
- Primary
- Secondary
- Dopamine agonists
- Elagolix
- Endometriosis
- Goserelin
- Letrozole
- Acetaminophen
- Agonists
- Antagonists
- Aromatase inhibitors
- Danazol
Question 2
Read the patient case on the next page, then answer the question that follows. While answering the question, click the clipboard to review the patient information at any time.
Question 2
WN is a 20-year-old female with complaints of recurrent symptoms in the week before her period. She reports that she already has some anxiety which is normally controlled with low-dose buspirone, but it worsens significantly during this time. She avoids activities she normally enjoys, struggles to concentrate in class, and often turns down plans with friends. She also experiences abdominal bloating and frequent headaches. These symptoms interfere with her daily life, last about one week, and improve once her period begins. She does not engage in sexual activity that could result in pregnancy. PMH: generalized anxiety disorder Meds: buspirone 7.5 mg BID, ibuprofen PRN (HAs)
Question 2
Question 2
Based on severity, volume, and presence of affective symptoms, WN likely has PMDD. SSRIs are first-line therapy for PMDD (fluoxetine). If an initial trial of an SSRI failed, it could be appropriate to try another SSRI or an SNRI like duloxetine. Since SSRIs are first-line, adding an SSRI is likely a more appropriate choice than increasing buspirone. Both anxiolytics (alprazolam) and combined oral contraceptives are second-line therapy for PMDD.
- Age: 20 | Sex: female
- PMH: generalized anxiety disorder
- Meds: buspirone 7.5 mg BID, ibuprofen PRN (headaches)
- Sexual history: no sex that could result in pregnancy
- CC: recurrent disruptive symptoms week before period that improve once period starts
- Avoids normally enjoyable activities, plans with friends
- Trouble concentrating
- Bloating
- Frequent headaches
Menstruation disorders - mobile
Madeleine Kochis
Created on October 5, 2025
Start designing with a free template
Discover more than 1500 professional designs like these:
View
Explainer Video: AI for Companies
View
Explainer Video: Keys to Effective Communication
View
Corporate CV
View
Flow Presentation
View
Discover Your AI Assistant
View
Urban Illustrated Presentation
View
Geographical Challenge: Drag to the map
Explore all templates
Transcript
Instructions
This self-assessment study guide has 2 questions, each written using learning objectives from your Menstruation Disorders lecture. Not all learning objectives are covered. Participation/scores are not monitored. FYI this program makes noise sometimes.
Symbols
A clipboard will bring up relevant patient information.
A lightbulb in the top right corner of a page indicates that the page contains answers or explanations.
Question 1
The next two pages narrate a patient being diagnosed with a menstrual disorder and choosing treatment. Fill in each blank space with a term from the word bank. Type the correct answer into the corresponding box. Capatilization shouldn't matter. Press "send" after you enter your answer to recieve feedback. Alternatively, you may wait until you type all of the answers for each page before pressing the send buttons.
Question 1
A 35-year-old patient presents with abdominal pain that lasts around 2.5 weeks every month and persists through the end of her period. Based on those symptoms, it is determined that she has 1 dysmenorrhea. She is ultimately diagnosed with 2 , a disorder defined by growth of endometrial tissue outside of the uterus. She fails all first-line treatments, which include 3 , combined hormonal, and progestin-only contraceptives. This leaves her with alternative options.
Question 1
The patient learns more about the side effect profiles of the remaining options. GnRH 4 are associated with a painful gonadotropic flare at the beginning of therapy. Classes of medications that can cause decreased BMD include GnRH agonists, GnRH antagonists, and 5 . The patient ends up being prescribed 6 , as she is okay with its potential adverse effects which include hirsutism, weight gain, and deepening of voice.
Question 2
Read the patient case on the next page, then answer the question that follows. While answering the question, click the clipboard to review the patient information at any time.
Question 2
WN is a 20-year-old female with complaints of recurrent symptoms in the week before her period. She reports that she already has some anxiety which is normally controlled with low-dose buspirone, but it worsens significantly during this time. She avoids activities she normally enjoys, struggles to concentrate in class, and often turns down plans with friends. She also experiences abdominal bloating and frequent headaches. These symptoms interfere with her daily life, last about one week, and improve once her period begins. She does not engage in sexual activity that could result in pregnancy. PMH: generalized anxiety disorder Meds: buspirone 7.5 mg BID, ibuprofen PRN (HAs)
Question 2
Question 2
Based on severity, volume, and presence of affective symptoms, WN likely has PMDD. SSRIs are first-line therapy for PMDD (fluoxetine). If an initial trial of an SSRI failed, it could be appropriate to try another SSRI or an SNRI like duloxetine. Since SSRIs are first-line, adding an SSRI is likely a more appropriate choice than increasing buspirone. Both anxiolytics (alprazolam) and combined oral contraceptives are second-line therapy for PMDD.